In our previous study, we demonstrated that although anti-IgM increased global mRNA translation in normal B cells, this was not associated with the changes in expression of eIF4A or PDCD4 that were observed in CLL cells [22]. The gene discussed is EIF4A1; the disease is B-cell chronic lymphocytic leukemia.